Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB25FPAQV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,424
Award facts
- Contract value 100% obligated
- $3,424.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,424.46 by the Defense Logistics Agency on August 19, 2025. The contract calls for the delivery of Xolair 300 mg/2 ml auto-injector vials, a biologic medication used primarily for severe asthma and other allergic conditions. This delivery order was issued without a set-aside designation, and performance is scheduled for completion by September 10, 2025, with the delivery location in Park Ridge, Illinois.
This award represents a single delivery order issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the Defense Logistics Agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to support the medical supply needs of military healthcare facilities worldwide. DMS Pharmaceutical Group's established status as a critical supplier within the federal pharmaceutical supply chain positions it to efficiently distribute specialized medications such as Xolair directly to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FPAQV?
SPE2DB25FPAQV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FPAQV worth?
The government has obligated $3,424 on SPE2DB25FPAQV.
Is contract SPE2DB25FPAQV an order under another contract?
Yes. SPE2DB25FPAQV is a delivery order under SPE2DB25D9336, an indefinite delivery contract.
Was contract SPE2DB25FPAQV competed?
The extent of competition for SPE2DB25FPAQV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award